Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edward L. Kunkel currently holds 212,500 shares of SANGUINE CORP (SGNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward L. Kunkel has been a net seller of SGNC stock. They have purchased $0 and sold $30.5K worth of shares.
Edward L. Kunkel's most recent insider trade was on Apr 10, 2008, when they sold 50,000 shares at $0.10 per share.
Edward L. Kunkel serves as Executive at SANGUINE CORP (SGNC). They have executed 13 insider transactions totaling $30.5K over their tenure at the company.
Edward L. Kunkel holds the position of Executive at SANGUINE CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Edward L. Kunkel has shown a selling trading pattern, with $0 in total purchases and $30.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Edward L. Kunkel was on Jan 15, 2008, when they sold $7.5K worth of SGNC shares. This transaction involved 75,000 shares at $0.10 per share.
Edward L. Kunkel currently owns 212,500 shares of SANGUINE CORP (SGNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edward L. Kunkel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edward L. Kunkel has 13 Form 4 filings on record as an insider at SANGUINE CORP.
Set alerts for Edward L. Kunkel and 40,000+ other insiders.